CVS HEALTH Corp - Common Stock (CVS)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CVS on NYSE
CUSIP
126650100
Type / Class
Equity / Common Stock
Shares outstanding
1.27B
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.09B
Holdings value
$82.3B
% of all portfolios
0.054%
Grand Portfolio weight change
+0%
Number of holders
1802
Number of buys
850
Number of sells
-821
Average Value change %
+0%
Average buys %
+0.009%
Average sells %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CVS HEALTH Corp - Common Stock (CVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.3% +17.1% $7.26B $1.11B 105M +18% BlackRock, Inc. Jun 30, 2025
Capital World Investors 5.5% $4.53B 68.8M Capital World Investors Mar 31, 2025

Institutional Holders of CVS HEALTH Corp - Common Stock (CVS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.09B $82.3B +$84.6M $75.39 1,802
2025 Q2 1.09B $75.4B +$2.25B $68.98 1,738
2025 Q1 1.06B $72B +$1.9B $67.75 1,723
2024 Q4 1.04B $46.9B +$1.64B $44.89 1,624
2024 Q3 999M $62.9B -$1.66B $62.88 1,812
2024 Q2 1.02B $60.2B +$1.94B $59.06 1,861
2024 Q1 987M $78.6B -$2.35B $79.76 2,109
2023 Q4 1.02B $80.2B +$2.66B $78.96 2,203
2023 Q3 981M $68.5B -$583M $69.82 2,064
2023 Q2 992M $68.6B -$273M $69.13 2,155
2023 Q1 989M $73.5B -$2.44B $74.31 2,208
2022 Q4 1.02B $95.4B -$578M $93.19 2,365
2022 Q3 1.03B $98.5B +$540M $95.37 2,284
2022 Q2 1.03B $95.2B +$462M $92.66 2,275
2022 Q1 1.03B $104B -$146M $101.21 2,332
2021 Q4 1.03B $106B +$785M $103.16 2,310
2021 Q3 1.01B $86.1B +$15.8M $84.86 2,050
2021 Q2 1.02B $84.7B +$2.04B $83.44 2,045
2021 Q1 992M $74.6B +$1.07M $75.23 2,007
2020 Q4 994M $67.9B +$25.2M $68.30 1,952
2020 Q3 995M $58.1B -$1.24B $58.40 1,792
2020 Q2 1.01B $65.8B +$771M $64.97 1,842
2020 Q1 1B $59.5B -$599M $59.33 1,785
2019 Q4 1.01B $74.8B +$96.8M $74.29 1,824
2019 Q3 1.01B $63.5B +$655M $63.07 1,671
2019 Q2 999M $54.4B -$126M $54.49 1,642
2019 Q1 1.01B $54.7B -$2.45B $53.93 1,692
2018 Q4 1.06B $69.2B +$12.1B $65.52 1,762
2018 Q3 870M $68.4B +$1.89B $78.72 1,605
2018 Q2 850M $54.7B +$263M $64.35 1,568
2018 Q1 854M $53.1B +$31.9M $62.21 1,544
2017 Q4 853M $61.7B +$961M $72.50 1,593
2017 Q3 837M $68.1B +$53.8M $81.32 1,526
2017 Q2 837M $67.4B -$474M $80.46 1,543
2017 Q1 844M $66.3B +$3.45B $78.50 1,570
2016 Q4 864M $68.2B -$1.22B $78.91 1,538
2016 Q3 876M $77.9B +$253M $88.99 1,547
2016 Q2 873M $83.6B -$2.31B $95.74 1,560
2016 Q1 893M $92.6B -$2.34B $103.73 1,543
2015 Q4 919M $89.9B -$1.17B $97.77 1,545
2015 Q3 931M $89.8B +$413M $96.48 1,498
2015 Q2 933M $97.9B -$614M $104.88 1,474
2015 Q1 939M $96.9B -$2.01B $103.21 1,444
2014 Q4 959M $92.4B -$1.17B $96.31 1,402
2014 Q3 968M $77B -$334M $79.59 1,278
2014 Q2 968M $72.9B -$1.48B $75.37 1,259
2014 Q1 988M $73.9B -$605M $74.86 1,222